Tissue fractions from human and animal livers represent an important tool in preclinical metabolism studies for predicting the toxicity and pharmacokinetic properties of a drug compound. Liver microsomes from humans and animal species play an important role in evaluating drug compounds for metabolic stability, reactive metabolites, drug-drug
interactions, reaction phenotyping, and metabolite identification.